Nivolumab
Advanced melanoma patient receives Keytruda infusion
1 Jul 2016
From today, patients with advanced melanoma will be able to access two publicly funded immunotherapy treatments - Opdivo and Keytruda, including Aucklander Barry Hawes. Video, Audio
Australia signs off on Keytruda alternative Nivolumab
3 May 2016
Last night we revealed a claim by the drug company that makes melanoma drug Keyrtruda that Pharmac has been using incorrect data, which gives a "false and misleading impression of how effective the… Audio